CytomX (CTMX) Stock Sees Significant Increase Following Key Announcement
In the recent trading session, CytomX Therapeutics, Inc. (NASDAQ: CTMX) stock has seen a notable surge in its value. As the US markets concluded the trading on Wednesday, CytomX experienced a remarkable escalation of 214.72% to close the session at $5.13. This surge in CTMX shares followed the announcement of the forthcoming release of both […]
